Hjem › Hidradenitis suppurativa › Florida
Hidradenitis suppurativa kliniske forsøg i Florida
10 studier for Hidradenitis suppurativa søger deltagere på steder i Florida.
Byer i Florida
Officiel studietekst (engelsk)
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- Floridian Research Institute, Miami
- University Of South Florida, Tampa
RekruttererFase 3
Alder 18 til 100 · Alle køn · Opdateret 28. sep. 2026 · NCT07665437A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- Encore Medical Research of Boynton Beach- Site Number : 8400005, Boynton Beach
- FXM Clinical Research - Fort Lauderdale- Site Number : 8400013, Fort Lauderdale
- Alliance for Multispeciality Research - Fort Myers- Site Number : 8400007, Fort Myers
- og 5 flere
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07225569A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- Up0122 103, South Miami
RekruttererFase 1
Alder 18 og opefter · Kvinder · Opdateret 18. sep. 2026 · NCT06888193Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US002, Boca Raton
- Investigative Site US084, Coral Gables
- Investigative Site US017, Hialeah
- og 14 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT06855498Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
- International Clinical Research Tennessee Llc, Sanford
- Lenus Research Medical Group, Llc, Sweetwater
- Trueblue Clinical Research, Tampa
RekruttererFase 1
Alder 12 til 75 · Alle køn · Opdateret 15. sep. 2026 · NCT07049575Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
- FXM Clinical Research - Miami- Site Number : 8400017, Miami
- FXM Clinical Research - Miramar- Site Number : 8400004, Miramar
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 20. aug. 2026 · NCT07170917Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- University of Miami Miller School of Medicine, Miami
- Skin Research of South Florida, Llc, Miami
- Trueblue Clinical Research, Tampa
RekruttererFase 2
Alder 12 til 17 · Alle køn · Opdateret 6. aug. 2026 · NCT07213973A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
- Accel Research Sites Network, Maitland
- Floridian Research Institute, Miami
- Cordova Research Institute, Miami
- og 4 flere
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 22. jul. 2026 · NCT07384975Myriad™ Augmented Soft Tissue Reconstruction Registry
- Asencion Sacred Heart, Pensacola
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 15. jul. 2026 · NCT05243966A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
- Direct Helpers Research Center, Hialeah
- Advanced Clinical Research Institute, Tampa
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 6. mar. 2026 · NCT07244263Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.